SKAN Group AGXSWX:SKAN +2.16%82 Market Cap is CHF1,277.1 Mil as of Jul. 10, 2026. GuruFocus rates XSWX:SKAN with a GF Score™ of 82/100 and a GF Value™ of CHF85.80 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 866 Medical Devices & Instruments companies, SKAN Group AG ranks better than 84.76% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). SKAN Group AG's share price for the quarter that ended in Dec. 2025 was CHF52.8. SKAN Group AG's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 22.5 Mil. Therefore, SKAN Group AG's market cap for the quarter that ended in Dec. 2025 was CHF1,187.2 Mil.
SKAN Group AG's quarterly market cap
declined
from Dec. 2024 (CHF1,713.3 Mil) to Jun. 2025 (CHF1,609.9 Mil) and
declined
from Jun. 2025 (CHF1,609.9 Mil) to Dec. 2025 (CHF1,187.2 Mil).
SKAN Group AG's annual market cap
declined
from Dec. 2023 (CHF1,816.7 Mil) to Dec. 2024 (CHF1,713.3 Mil) and
declined
from Dec. 2024 (CHF1,713.3 Mil) to Dec. 2025 (CHF1,187.2 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. SKAN Group AG's Enterprise Value for Today is CHF1,327.6 Mil.
SKAN Group AG (XSWX:SKAN) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
SKAN Group AG Market Cap Related Terms
SKAN Group AG Market Cap Historical Data
* Premium members only.
The historical data trend for SKAN Group AG's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:SKAN vs ISRG, BDX, MDLN: Market Cap Comparison
For the Medical Instruments & Supplies subindustry, SKAN Group AG's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SKAN Group AG Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SKAN Group AG's Market Cap distribution charts can be found below:
* The bar in red indicates where SKAN Group AG's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
SKAN Group AG's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SKAN Group AG (XSWX:SKAN) has a Market Cap of CHF1,277.1 Mil as of Jul. 10, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on SKAN Group AG and its competitors. According to the industry distribution chart, SKAN Group AG ranks #132 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 15.2%.
Is SKAN Group AG's Market Cap too high?
SKAN Group AG's current Market Cap is CHF1,277.1 Mil. Based on the distribution chart, SKAN Group AG ranks #132 out of 866 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, SKAN Group AG has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SKAN Group AG's Market Cap compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, SKAN Group AG ranks #132 out of 866 companies for Market Cap. This places SKAN Group AG in the top 15% of its industry — outperforming the majority of peers. The industry median Market Cap is 116.25. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 116.25, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on SKAN Group AG and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 116.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SKAN Group AG's current Market Cap is CHF1,277.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SKAN Group AG stock overvalued right now?
Based on GuruFocus' analysis, SKAN Group AG (XSWX:SKAN) is currently considered Significantly Undervalued. The stock's GF Value™ is CHF85.80, compared to a current price of CHF56.80 — trading 33.8% below its estimated fair value. The current Market Cap is CHF1,277.1 Mil. SKAN Group AG's overall GF Score™ is 82/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For SKAN Group AG (XSWX:SKAN), the current Market Cap is CHF1,277.1 Mil as of Jul. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SKAN Group AG (XSWX:SKAN) Overvalued in 2026?
Based on GuruFocus' analysis, SKAN Group AG stock appears to be undervalued.
The current stock price of CHF56.80 is trading 33.8% below its estimated GF Value™ of CHF85.80.
GuruFocus considers SKAN Group AG to be Significantly Undervalued.
Key valuation signals for XSWX:SKAN:
Market Cap: CHF1,277.1 Mil
GF Value™: CHF85.80 vs. price of CHF56.80 (33.8% below fair value)
No single metric tells the full story. See the XSWX:SKAN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SKAN Group AG is a market and technological company for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances. The company offers its customers process support, services, and consumables. Its products include biological indicators, isolators, Laboratory/cleanroom equipment, laminar flow, safety workbenches, transfer systems, and others. The Firm has three operating segments: Equipment & solutions, Services & Consumables, and Other. The company generates the majority of its revenue from the Equipment & solutions segment. Geographically, the company derives revenue from Asia, Europe, Americas, and Other regions.
82GF Score
Get the complete analysis for XSWX:SKAN
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:SKAN has been successfully added to your 
